BTIG Reiterates Buy on Connect Biopharma Hldgs, Maintains $10 Price Target

BTIG analyst Julian Harrison has reiterated a 'Buy' rating on Connect Biopharma Holdings (NASDAQ: CNTB) and has maintained a price target of $10 for the stock.